Can a common antibiotic shield the brain after a stroke?
NCT ID NCT05487417
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial investigates whether the antibiotic minocycline can reduce brain injury in people with acute ischemic stroke who undergo mechanical thrombectomy (clot removal). Minocycline may protect the blood-brain barrier and limit damage from restored blood flow. The study enrolls adults aged 18–85 with large-vessel anterior circulation stroke and measures changes in infarct volume and functional recovery at three months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- the antibiotic minocycline
- What this could lead to
- If it works, minocycline could become a simple, widely available add-on treatment to reduce brain damage and improve outcomes after stroke thrombectomy.
- What could go wrong
- This is a mid-stage trial with 189 participants, so results may not apply to all stroke patients. Minocycline can cause side effects like dizziness, nausea, and antibiotic-related risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
189 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients with acute cerebral infarction of anterior circulation accompanied by large vessel occlusion; 2. Age 18-85 years old; 3. The time of onset ≤ 6 hours or ≤ 24 hours suitable for mechanical thrombectomy determined by multimodal imaging; 4. The time of onset 6-24 hours, DWI shows an infarct volume less than 1/3 of the MCA blood supply area; the time of onset ≤ 6 hours, the ASPECTS(Alberta Stroke Program Early CT Score) is ≥6; 5. Preoperative NIHSS score ranges from 6 to 30 points; 6. Sign the informed consent form; Exclusion Criteria: 1. There are contraindications for mechanical thrombectomy; 2. No revascularization therapy was performed during the operation or the TICI score after revascularization therapy was less than 2b; 3. There are other major central nervous system diseases, such as brain injury, brain tumor, multiple sclerosis, etc; 4. There is evidence that the patient has bacterial endocarditis, aortic dissection, arteritis or venous cerebral infarction; 5. Renal insufficiency or hepatic insufficiency (serum creatinine \>2.0 mg/dL or 180 µmol/L; liver function greater than 3 times the normal value); 6. Known history of congestive heart failure (requiring dietary or medication changes or hospitalization) within 6 months, or myocardial infarction within 6 months; 7. There is evidence of any other life-threatening or severe diseases that may hinder the completion of the 3-month follow-up and affect the evaluation of the results; 8. Pre-existing neurological deficits or history of dementia; 9. There are infectious diseases that require antibiotic treatment before the disease; 10. Allergic to tetracyclines or unable to take minocycline for other reasons; 11. Minocycline could not be given within 1 hour after recanalization; 12. Pregnant patients; 13. Participated in another clinical trial within 30 days before inclusion in the study. 14. Refuse to sign the informed consent form.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute anterior circulation ischemic stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xijing Hospital
Xi'an, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI as a second opinion for stroke: a smarter path to Clot-Busting?
- Can an earthworm enzyme boost stroke recovery?
- Can a Rapid-Acting clot blocker boost stroke recovery?
- Can a simple relaxation technique soothe the mind after a stroke?
- Stroke care at a distance: can video consultations speed up Life-Saving treatment?
- Herbal capsule may boost brain repair after stroke